Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins - Blaeschke, Franziska; Stenger, Dana; Apfelbeck, Antonia; Cadilha, Bruno L.; Benmebarek, Mohamed-Reda; Mahdawi, Jasmin; Ortner, Eva; Lepenies, Mareike; Habjan, Nicola; Rataj, Felicitas; Willier, Semjon; Kaeuferle, Theresa; et al. (Blood cancer journal (New York), 2021)
Keywords: 13/31; 13/44; 631/250/251; 631/67/1990/283/2125; 692/699/1541/1990/283/2125; Antigens, CD19 - immunology; Biomedical and Life Sciences; Biomedicine; Cancer Research; CD28 Antigens - therapeutic use; Cell Line, Tumor; Correspondence; Hematology; Humans; Immunotherapy, Adoptive; Oncology; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy; Programmed Cell Death 1 Receptor - therapeutic use; Receptors, IgE - immunology; Recombinant Fusion Proteins - pharmacology